P
85.66
3.33 (4.04%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Palvella Therapeutics, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
2.6
| 分析师共识 | 3.0 |
| 内部交易活动 | 3.0 |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 5.0 |
| 技术振荡指标 | 4.0 |
| 平均 | 2.60 |
|
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company’s lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company’s patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 22.87% |
| 机构持股比例 | 47.68% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 255.00 (HC Wainwright & Co., 197.69%) | 购买 |
| 中 | 210.00 (145.16%) | |
| 低 | 133.00 (TD Cowen, 55.27%) | 购买 |
| 平均值 | 208.14 (142.98%) | |
| 总计 | 7 购买 | |
| 平均价格@调整类型 | 112.64 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| BTIG | 25 Feb 2026 | 215.00 (150.99%) | 购买 | 128.60 |
| 29 Jan 2026 | 192.00 (124.14%) | 购买 | 81.90 | |
| Mizuho | 25 Feb 2026 | 250.00 (191.85%) | 购买 | 128.60 |
| 07 Jan 2026 | 205.00 (139.32%) | 购买 | 101.03 | |
| Chardan Capital | 24 Feb 2026 | 210.00 (145.16%) | 购买 | 120.41 |
| 16 Dec 2025 | 174.00 (103.13%) | 购买 | 96.81 | |
| HC Wainwright & Co. | 24 Feb 2026 | 255.00 (197.69%) | 购买 | 120.41 |
| 15 Dec 2025 | 200.00 (133.48%) | 购买 | 88.98 | |
| Canaccord Genuity | 16 Dec 2025 | 204.00 (138.15%) | 购买 | 96.81 |
| TD Cowen | 16 Dec 2025 | 133.00 (55.27%) | 购买 | 96.81 |
| Truist Securities | 16 Dec 2025 | 190.00 (121.81%) | 购买 | 96.81 |
| 显示更多 | ||||
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| HERON ELAINE J | 135.02 | - | 2,400 | 324,048 |
| JENKINS GEORGE M | 135.02 | - | 4,000 | 540,080 |
| 累积净数量 | 6,400 | |||
| 累积净值 ($) | 864,128 | |||
| 累积平均购买 ($) | 135.02 | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| HERON ELAINE J | 董事 | 27 Feb 2026 | 买 (+) | 2,400 | 135.02 | 324,048 |
| JENKINS GEORGE M | 董事 | 27 Feb 2026 | 买 (+) | 4,000 | 135.02 | 540,080 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合